Sutskever, I., Martens, J
#CongestiveHeartFailure #Pharmacology #LoopDiuretic #ACEInhibiors #BetaBlockers #CardiacGlycosides #Vasodilators #ARBs #Doctor #medical #CHF To view or add a comment, sign in Weight-loss drug reduces heart risks The weight-loss drug semaglutide, found in Wegovy and Ozempic, cuts the risk of cardiovascular problems such as heart attack or stroke, regardless of how much weight people lose, according to a new study published in the Lancet
2003) co stao si gwnym argumentem za jego pozycj w pimiennictwie nad longevity
Alongside the anti-inflammatory benefits, L-carnitine supplementation results in several improvements in health outcomes, which may influence susceptibility to viral infection
A.ScortecciJ
Quercetin, a dietary flavonol, has emerged as a promising multi-target neuroprotective compound